Market cap
$44,183 Mln
Revenue (TTM)
$4,446 Mln
P/E Ratio
41.2
P/B Ratio
29.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.7 %
-
ROCE
46.6 %
-
Industry P/E
45.24
-
EV/EBITDA
29.9
-
Debt to Equity
0.2
-
Book Value
$20.1
-
EPS
$13.6
-
Face value
--
-
Shares outstanding
78,882,997
10 Years Aggregate
CFO
$4,872.40 Mln
EBITDA
$6,702.20 Mln
Net Profit
$4,514.68 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
IDEXX Laboratories (IDXX)
| -17.2 | -2.6 | -13.0 | 15.1 | 4.7 | 0.6 | 20.5 |
|
BSE Sensex
| -8.7 | 3.6 | -7.5 | -4.2 | 8.2 | 9.5 | 11.9 |
|
S&P 100
| 6.4 | 14.0 | 7.7 | 35.2 | 24.6 | 13.9 | 15.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
IDEXX Laboratories (IDXX)
| 63.6 | -25.3 | 36.1 | -38.0 | 31.7 | 91.4 | 40.4 |
|
S&P 100
| 18.7 | 29.0 | 30.8 | -22.1 | 27.6 | 19.3 | 29.5 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
IDEXX Laboratories (IDXX)
|
560.1 | 44,183.2 | 4,446.1 | 1,095.2 | 23.5 | 70.3 | 41.2 | 29.4 |
| 84.3 | 146,869.7 | 45,134.0 | 6,276.0 | 15.4 | 12.2 | 23.6 | 2.9 | |
| 149.4 | 41,174.0 | 21,365.0 | 1,138.0 | 9.9 | 4.6 | 26.1 | 1.6 | |
| 53.9 | 80,159.1 | 20,615.0 | 3,553.0 | 10.0 | 14.5 | 22.6 | 3.2 | |
| 171.2 | 124,327.0 | 24,778.0 | 3,689.0 | 18.7 | 7.1 | 34 | 2.3 | |
| 80.0 | 46,041.0 | 6,303.5 | 1,092.8 | 12.7 | 10.6 | 43.2 | 4.6 | |
| 450.1 | 159,394.5 | 10,582.1 | 2,979.1 | 22.4 | 17.2 | 54.6 | 9.2 | |
| 285.5 | 112,685.5 | 25,270.0 | 3,337.0 | 14.8 | 15.1 | 34 | 5.0 | |
| 465.0 | 176,319.5 | 45,197.0 | 6,859.0 | 19.2 | 13.3 | 26.1 | 3.4 | |
| 355.1 | 34,861.5 | 3,770.6 | 449.3 | 16.3 | 5.1 | 45.2 | 2.2 |
Shareholding Pattern
View DetailsAbout IDEXX Laboratories (IDXX)
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments:... Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine. Read more
-
President, CEO & Director
Mr. Jonathan J. Mazelsky
-
President, CEO & Director
Mr. Jonathan J. Mazelsky
-
Headquarters
Westbrook, ME
-
Website
FAQs for IDEXX Laboratories (IDXX)
What is the current share price of IDEXX Laboratories Inc (IDXX) Today?
The share price of IDEXX Laboratories Inc (IDXX) is $560.11 (NASDAQ) as of 08-May-2026 16:00 EDT. IDEXX Laboratories Inc (IDXX) has given a return of 4.67% in the last 3 years.
What is the current PB & PE ratio of IDEXX Laboratories Inc (IDXX)?
The P/E ratio of IDEXX Laboratories Inc (IDXX) is 41.15 times as on 08-May-2026, a 9 discount to its peers’ median range of 45.24 times.
The P/B ratio of IDEXX Laboratories Inc (IDXX) is 29.36 times as on 08-May-2026, a 902 premium to its peers’ median range of 2.93 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
51.52
|
34.00
|
|
2024
|
38.68
|
21.52
|
|
2023
|
55.13
|
31.38
|
|
2022
|
50.35
|
56.17
|
|
2021
|
76.15
|
82.21
|
What is the 52 Week High and Low of IDEXX Laboratories Inc (IDXX)?
The 52-week high and low of IDEXX Laboratories Inc (IDXX) are Rs 769.98 and Rs 485.41 as of 10-May-2026.
What is the market cap of IDEXX Laboratories Inc (IDXX)?
IDEXX Laboratories Inc (IDXX) has a market capitalisation of $ 44,183 Mln as on 08-May-2026. As per SEBI classification, it is a Large Cap company.
Should I invest in IDEXX Laboratories Inc (IDXX)?
Before investing in IDEXX Laboratories Inc (IDXX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.